Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Folasync DHA
- Development stage
- Unknown
- Lead developer
- Blue Heron Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Folasync DHA is a prescription-grade nutritional supplement or medical food marketed by Blue Heron Pharmaceuticals. It is formulated as a combination of levomefolate calcium (the active form of folate) and docosahexaenoic acid (DHA), an essential omega-3 fatty acid. The product is designed for the clinical dietary management of conditions associated with folate deficiency and is frequently utilized in prenatal and postnatal care to support fetal neural development and maternal nutritional status. Unlike synthetic folic acid, levomefolate does not require enzymatic conversion by methylenetetrahydrofolate reductase (MTHFR), making it bioavailable for individuals with MTHFR polymorphisms.
- Brand names
- Folasync DHA
- Other names
- Folasync DHA Capsules
02
Targets
PPARG (Peroxisome proliferator-activated receptor gamma)FOLR1 (FRα)
Beyond the preview
Go deeper on Folasync DHA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Folasync DHA.